|
MAGEE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.44280000169417E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76869999757301E-08 |
| Normal-vs-Stage2 |
1.400440E-01 |
| Normal-vs-Stage3 |
1.08970000023412E-07 |
| Normal-vs-Stage4 |
1.19319998326262E-09 |
| Stage1-vs-Stage2 |
7.797600E-03 |
| Stage1-vs-Stage3 |
2.929800E-01 |
| Stage1-vs-Stage4 |
4.405600E-02 |
| Stage2-vs-Stage3 |
1.601480E-03 |
| Stage2-vs-Stage4 |
1.995460E-04 |
| Stage3-vs-Stage4 |
2.667000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.95400004457491E-09 |
| Normal-vs-AfricanAmerican |
1.393600E-02 |
| Normal-vs-Asian |
1.585270E-04 |
| Caucasian-vs-AfricanAmerican |
2.340800E-01 |
| Caucasian-vs-Asian |
3.711600E-01 |
| AfricanAmerican-vs-Asian |
6.533400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.41340000042933E-07 |
| Normal-vs-Female |
3.42399999464504E-08 |
| Male-vs-Female |
7.817200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.15430004127882E-09 |
| Normal-vs-Age(41-60Yrs) |
2.33029999996415E-06 |
| Normal-vs-Age(61-80Yrs) |
1.59633999999853E-05 |
| Normal-vs-Age(81-100Yrs) |
1.158460E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.707800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.540800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.902600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.462000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.707000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.432600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.577750E-03 |
| Classical-VS-Follicular |
3.774800E-01 |
| Classical-VS-Other |
2.765200E-01 |
| Classical-VS-Normal |
2.19949999991087E-07 |
| Tall-VS-Follicular |
1.441370E-03 |
| Tall-VS-Other |
8.640800E-01 |
| Tall-VS-Normal |
1.30480004578715E-09 |
| Follicular-VS-Other |
2.253400E-01 |
| Follicular-VS-Normal |
5.641900E-04 |
| Other-VS-Normal |
3.281800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.7991000000055E-05 |
| Normal-vs-N1 |
1.07310049735077E-10 |
| N0-vs-N1 |
2.636300E-04 |
|
|
